Related Experiment Videos

Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease

Erik Kjoller1, Jorgen Hilden, Per Winkel

  • 1Department of Cardiology, Copenhagen University Hospital, Herlev Hospital, Herlev Ringvej 75, Herlev, Denmark. kjoller@dadlnet.dk

Insights

Cardiology specialists achieved good agreement on outcomes in stable coronary heart disease trials. This ensures reliable intervention effect estimations in clinical research.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Medical Research

Background:

  • Accurate outcome assessment is crucial for valid clinical trial results.
  • Limited data exists on adjudicator agreement in cardiology trials.
  • This study addresses the need to evaluate agreement among specialists in stable coronary heart disease.

Purpose of the Study:

  • To assess the level of agreement among three cardiology specialists.
  • To evaluate the adjudication of events in a randomized controlled trial for stable coronary heart disease patients.

Main Methods:

  • Three blinded cardiology specialists adjudicated all events.
  • Two adjudicators reviewed cases; a third arbitrated disagreements.
  • Data included 5,475 nonfatal and 362 fatal events.

Main Results:

  • Pairwise kappa values for nonfatal outcomes ranged from 0.75-0.80.
  • Adjudicator classifications were overruled in 4.3%-9.5% of nonfatal outcomes.
  • Pairwise kappa values for fatal outcomes ranged from 0.65-0.90, with 9%-12% overruled.

Conclusions:

  • Cardiology specialists can achieve reasonably high agreement on outcomes.
  • This level of agreement supports the validity of intervention effect estimations in stable coronary heart disease trials.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...